Loading...
•
Sep 30, 2024
McKesson Q2 2025 Earnings Report
McKesson reported record revenue and adjusted earnings growth, driven by strong performance in the U.S. Pharmaceutical segment.
Key Takeaways
McKesson Corporation announced strong second-quarter results, with a 21% increase in consolidated revenues to $93.7 billion and a 13% increase in Adjusted Earnings per Diluted Share to $7.07. The company also raised its full-year adjusted EPS guidance to $32.40 to $33.00.
Consolidated revenues increased by 21% to $93.7 billion.
Adjusted Earnings per Diluted Share grew by 13% to $7.07.
Full-year Adjusted Earnings per Diluted Share guidance raised to $32.40 to $33.00.
Agreement announced to acquire a controlling interest in Florida Cancer Specialists & Research Institute LLC's Core Ventures.
Revenue by Segment
Forward Guidance
McKesson is raising and narrowing fiscal 2025 Adjusted Earnings per Diluted Share guidance to $32.40 to $33.00 from the previous range of $31.75 to $32.55.
Positive Outlook
- Fiscal 2025 Adjusted Earnings per Diluted Share guidance range raised to $32.40 to $33.00.
- Fiscal 2025 Adjusted Earnings per Diluted Share guidance range indicates 18% to 20% growth compared to prior year.
- Full year share repurchases target raised from $2.8 billion to $3.2 billion.
- Fiscal 2025 Adjusted Earnings per Diluted Share guidance includes $0.53 related to year-to-date gains associated with McKesson Ventures' equity investments.
- Company remains confident in its ability to deliver against its fiscal 2025 outlook, which is above the long-term targets previously provided.
Challenges Ahead
- McKesson does not provide forward-looking guidance on a GAAP basis.
- McKesson cannot reasonably forecast LIFO inventory-related adjustments.
- McKesson cannot reasonably forecast certain litigation loss and gain contingencies.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...